* JPM THEMATICS-GENETIC THERAPIES C2 (DIST) USD | 30/05 | -18,21% |
| * JPM THEMATICS-GENETIC THERAPIES C (ACC) EUR (HEDGED) | 30/05 | -12,74% |
| * JPM THEMATICS-GENETIC THERAPIES C (ACC) USD | 30/05 | -18,25% |
| * JPM THEMATICS-GENETIC THERAPIES C (DIST) USD | 30/05 | -18,24% |
| * JPM THEMATICS-GENETIC THERAPIES D (ACC) EUR (HEDGED) | 30/05 | -13,27% |
| * JPM THEMATICS-GENETIC THERAPIES D (ACC) USD | 30/05 | -18,74% |
| * JPM THEMATICS-GENETIC THERAPIES I2 (ACC) EUR (HEDGED) | 30/05 | -12,70% |
| * JPM THEMATICS-GENETIC THERAPIES I2 (ACC) USD | 30/05 | -18,19% |
| * JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR | 30/05 | -18,18% |
| * JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR (HEDGED) | 30/05 | -12,74% |
| **** JPM TOTAL EMERGING MARKETS INCOME A (ACC) EUR | 30/05 | -2,14% |
| **** JPM TOTAL EMERGING MARKETS INCOME A (ACC) USD | 30/05 | -2,19% |
| * JPM TOTAL EMERGING MARKETS INCOME A (DIST) EUR | 30/05 | -2,13% |
| * JPM TOTAL EMERGING MARKETS INCOME A (DIV) EUR | 30/05 | -4,93% |
| ***** JPM TOTAL EMERGING MARKETS INCOME C (ACC) EUR | 30/05 | -1,83% |
| *** JPM TOTAL EMERGING MARKETS INCOME D (ACC) EUR | 30/05 | -2,39% |
| *** JPM TOTAL EMERGING MARKETS INCOME D (ACC) USD | 30/05 | -2,46% |
| * JPM TOTAL EMERGING MARKETS INCOME D (DIV) EUR | 30/05 | -5,19% |
| ** JPM TOTAL EMERGING MARKETS INCOME I2 (ACC) EUR (HEDGED) | 30/05 | 6,04% |
| * JPM TOTAL EMERGING MARKETS INCOME I (DIST) EUR (HEDGED) | 30/05 | 5,97% |
